XML 27 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Potentially Dilutive Securities

The following potentially dilutive securities have been excluded from the computation of diluted shares of common stock outstanding as they would be anti-dilutive:

 

   2023   2022 
   December 31, 
   2023   2022 
Common stock warrants August 2021   112,429    128,500 
Underwriter warrants August 2021   2,287    2,287 
Private warrants   —    90 
Chanticleer warrants   57    57 
Series C warrants   18,391    36,778 
Series 3 warrants   12,548    12,548 
Unvested restricted stock units and awards   7,840    10,002 
Common stock warrants February 2023   271,883    — 
Underwriter warrants February 2023   15,466    — 
Common stock private placement warrants June 2023   227,272    — 
Placement agent warrants June 2023   6,818    — 
Common stock warrants October 2023   5,687,500    — 
Underwriter warrants October 2023   85,312    — 
Total anti-dilutive weighted average shares   6,447,803    190,262